Zhonghua er ke za zhi. Chinese journal of pediatrics
-
Zhonghua Er Ke Za Zhi · Sep 2012
[Emergency use of extracorporeal membrane oxygenation in pediatric critically ill patients].
The history of clinical application of extracorporeal membrane oxygenation (ECMO) has been more than 30 years. But in China, there were only a few ECMO centers with limited successful cases reported by the end of twentieth century. The high morbidities and mortalities in current pediatric ECMO practice are noted in China. Therefore, it is necessary to review the experience on rescue use of ECMO in critically ill pediatric patients. ⋯ ECMO is a justifiable alternative treatment for reversible severe cardiopulmonary failure in critically ill children.
-
Zhonghua Er Ke Za Zhi · Sep 2012
[Carriage of the Pseudomonas aeruginosa virulence factors and prognosis after infection].
To investigate drug-resistance and carriage of virulence factors of Pseudomonas aeruginosa (Pa) isolated from children. ⋯ The above mentioned 34.21% of Pa isolated from children carried virulence factors toxA, norA, exoS, exoY, pyp and exoU. The strains with exoU/pyp had rather high resistance. The strains with pyp had strong toxicity, they easily cause generalized infection, the patients with them had very high mortality.
-
Zhonghua Er Ke Za Zhi · Sep 2012
[Changes and significance of soluble CD 163 in sepsis and severe sepsis in children].
To investigate the changes of serum soluble CD 163 (sCD 163) level, to assess the severity of critical illness and to evaluate the immune status of sepsis or severe sepsis in children. ⋯ Detection of sCD 163 was helpful in predicting the severity of sepsis and severe sepsis, and sCD 163 may reflect the immune status of critically ill children with sepsis.
-
Zhonghua Er Ke Za Zhi · Sep 2012
[Rituximab therapy for severe pediatric systemic lupus erythematosus].
To analyze the safety and efficacy of anti-CD20 monoclonal antibody in treatment of severe pediatric systemic lupus erythematosus (PSLE). ⋯ Anti-CD20 monoclonal antibody is effective and safe in treatment of severe PSLE. But severe infections may occur in some cases. Focusing on prevention and early treatment can reduce the probability of adverse reactions.